A. Orlando

发表

Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

V. Annese, P. Gionchetti, F. Rizzello, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease.

P. Gionchetti, F. Rizzello, S. Danese, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Severe Cutaneous Psoriasis After Certolizumab Pegol Treatment: Report of a Case

M. Cottone, A. Orlando, F. Mocciaro, 2009, The American Journal of Gastroenterology.

COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients’ Association

F. Manguso, F. Rizzello, A. Armuzzi, 2021, Inflammatory bowel diseases.

Mortality and Causes of Death in Celiac Disease in a Mediterranean Area

A. Rizzo, M. Cottone, A. Orlando, 1999, Digestive Diseases and Sciences.

Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis

G. Pietrosi, A. Rizzo, G. Martorana, 2001, American Journal of Gastroenterology.

Smoking habits and recurrence in Crohn's disease.

M. Traina, M. Cottone, A. Orlando, 1994, Gastroenterology.

Unmet needs of Italian physicians managing patients with inflammatory bowel disease.

F. Rizzello, A. Armuzzi, G. Manes, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Maintenance infliximab for Crohn's disease

M. Cottone, A. Orlando, L. Oliva, 2002, The Lancet.

Training Programs on Endoscopic Scoring Systems for Inflammatory Bowel Disease Lead to a Significant Increase in Interobserver Agreement Among Community Gastroenterologists

F. Rizzello, A. Armuzzi, R. D'Incà, 2016, Journal of Crohn's & colitis.

Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein.

M. Cottone, A. Orlando, M. Caltagirone, 1994, Journal of hepatology.

Music for colonoscopy: A single-blind randomized controlled trial.

G. D’Amico, A. Mancuso, A. Orlando, 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical data

A. Orlando, F. Macaluso, 2020, Digestive and Liver Disease.

Tolerability profile of thiopurines in inflammatory bowel disease: a prospective experience

M. Cottone, A. Orlando, M. Maida, 2017, Scandinavian journal of gastroenterology.

Cancer in Crohn's Disease patients treated with infliximab: A long‐term multicenter matched pair study

F. Rizzello, R. D'Incà, L. Biancone, 2011, Inflammatory bowel diseases.

Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study

E. Savarino, F. Manguso, A. Amato, 2022, Alimentary pharmacology & therapeutics.

Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology.

S. Bonovas, E. Savarino, F. Manguso, 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease.

V. Annese, P. Gionchetti, F. Rizzello, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Clinical course of ulcerative colitis.

M. Cottone, A. Orlando, F. Mocciaro, 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study.

P. Gionchetti, F. Rizzello, G. Fiorino, 2022, Inflammatory bowel diseases.

Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn's disease.

G. Cabibbo, C. Camma', M. Cottone, 2008, Gastroenterology.

Risk factors and timing for colectomy in chronically active refractory ulcerative colitis: A systematic review.

P. Gionchetti, A. Armuzzi, A. Orlando, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Patient and physician views on the quality of care in inflammatory bowel disease: results from SOLUTION-1, a prospective IG-IBD study.

S. Danese, M. Merli, R. D'Incà, 2014, Journal of Crohn's & colitis.

Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.

L. Guidi, A. Armuzzi, R. D'Incà, 2019, Inflammatory bowel diseases.

Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis

I. Olivieri, P. Gionchetti, A. Armuzzi, 2019, Clinical and experimental immunology.

Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease.

V. Annese, L. Guidi, P. Gionchetti, 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Meta‐analysis: remission and response from control arms of randomized trials of biological therapies for active luminal Crohn’s disease

M. Cottone, A. Orlando, F. Mocciaro, 2008, Alimentary pharmacology & therapeutics.

Investigational agents for Crohn's disease

M. Cottone, A. Orlando, S. Renna, 2010, Expert opinion on investigational drugs.

Are we choosing wisely for inflammatory bowel disease care? The IG-IBD choosing wisely campaign.

F. Rizzello, G. Fiorino, A. Armuzzi, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Course of Crohn’s Disease

M. Cottone, A. Orlando, A. Affronti, 2016 .

Methodology for high-quality studies on course and prognosis of inflammatory bowel disease.

M. Cottone, A. Orlando, I. Modesto, 2012, World journal of gastroenterology.

Comparing medical treatments for Crohn's disease.

M. Cottone, A. Orlando, S. Renna, 2013, Journal of comparative effectiveness research.

Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alfafetoprotein: a prospective study.

M. Cottone, A. Orlando, M. Caltagirone, 1988, Hepato-gastroenterology.

The Role of CARD15 Mutations and Smoking in the Course of Crohn's Disease in a Mediterranean Area

M. Cottone, A. Orlando, I. Modesto, 2008, The American Journal of Gastroenterology.

Effectiveness of Ustekinumab on Crohn‘s Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)

A. Magnano, W. Fries, A. Orlando, 2020, Expert opinion on biological therapy.

The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseases.

A. Magnano, M. Cottone, W. Fries, 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Spondyloarthropathy in Inflammatory Bowel Disease: From Pathophysiology to Pharmacological Targets

M. Grova, A. Orlando, S. Renna, 2022, Drugs.

Epidemiological trends in pediatric inflammatory bowel disease: The precious contribution of the registries promoted by scientific societies.

A. Orlando, F. Macaluso, 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Prevalence and incidence of inflammatory bowel disease in two Italian islands, Sicily and Sardinia: A report based on health information systems.

S. Scondotto, M. Cottone, A. Orlando, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

The biologics of ulcerative colitis

M. Cottone, A. Orlando, S. Renna, 2017, Expert opinion on biological therapy.

Intestinal Permeability and Genetic Determinants in Patients, First-Degree Relatives, and Controls in a High-Incidence Area of Crohn's Disease in Southern Italy

M. Cottone, W. Fries, A. Orlando, 2005, The American Journal of Gastroenterology.

Epidemiology of crohn's disease in Sicily: A hospital incidence study from 1987 to 1989

M. Cottone, A. Orlando, L. Oliva, 1991, European Journal of Epidemiology.

Letter: mesalazine—a safe drug with rare serious adverse events

A. Orlando, S. Renna, F. Macaluso, 2020, Alimentary pharmacology & therapeutics.

Infliximab and newly diagnosed neoplasia in Crohn’s disease: a multicentre matched pair study

F. Rizzello, L. Biancone, E. Calabrese, 2005, Gut.

Management of patients with complex perianal fistulas in Crohn's disease: Optimal patient flow in the Italian clinical reality.

P. Gionchetti, F. Rizzello, S. Danese, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Methodological problems in RCTs on IBD.

M. Cottone, A. Orlando, I. Modesto, 2012, Reviews on recent clinical trials.

Medical management of Crohn's disease

M. Cottone, A. Orlando, F. Mocciaro, 2011, Expert opinion on pharmacotherapy.

The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease.

V. Annese, P. Gionchetti, F. Rizzello, 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Familial occurrence of inflammatory bowel disease in celiac disease.

G. Martorana, E. Calabrese, M. Cottone, 2003 .

Mongersen , an Oral SMAD 7 Antisense Oligonucleotide , and Crohn ’ s Disease

M. Neurath, L. Biancone, S. Ardizzone, 2015 .

Minimizing infliximab toxicity in the treatment of inflammatory bowel disease.

M. Cottone, A. Orlando, F. Mocciaro, 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Real-life experience of infliximab biosimilar in pediatric-onset inflammatory bowel disease: data from the Sicilian Network for Inflammatory Bowel Disease

A. Busacca, A. Orlando, S. Pellegrino, 2022, European journal of gastroenterology & hepatology.

How clinicians and pathologists interact concerning inflammatory bowel disease in Italy: An IG-IBD survey.

F. Rizzello, A. Armuzzi, V. Villanacci, 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Mortality in patients with Crohn's disease.

M. Cottone, A. Orlando, M. Rosselli, 1996, Scandinavian journal of gastroenterology.

Frequency of thiopurine methyltransferase mutation in patients of Mediterranean area with inflammatory bowel disease and autoimmune disorders.

M. Cottone, A. Orlando, F. Macaluso, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Six year adalimumab efficacy in steroid-dependent Crohn's disease patients: A prospective single-center real life study.

M. Cottone, A. Orlando, A. Craxì, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Letter: a prospective real life comparison of the efficacy of adalimumab vs. golimumab in moderate to severe ulcerative colitis

M. Cottone, A. Orlando, M. Maida, 2016, Alimentary pharmacology & therapeutics.

Adalimumab in active ulcerative colitis: a "real-life" observational study.

V. Annese, L. Guidi, P. Gionchetti, 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches.

A. Magnano, W. Fries, A. Orlando, 2020, Inflammatory Bowel Diseases.

The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy.

V. Annese, A. Amato, F. Perri, 2018, Inflammatory bowel diseases.

The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar

S. Bonovas, A. Andriulli, V. Annese, 2017, Inflammatory bowel diseases.

Fatal necrotising fasciitis associated with intramuscular injection of nonsteroidal anti-inflammatory drugs after uncomplicated endoscopic polypectomy.

G. D’Amico, A. Rizzo, G. Tamburello, 2007, The Journal of infection.

Toxic megacolon and human Cytomegalovirus in a series of severe ulcerative colitis patients.

M. Cottone, A. Orlando, V. Criscuoli, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Severe acute colitis associated with CMV: a prevalence study.

A. Rizzo, M. Traina, M. Cottone, 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease.

M. Cottone, A. Orlando, S. Renna, 2014, World journal of gastroenterology.

Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients

A. Orlando, V. Calvaruso, A. Cascio, 2018, Infection.

Hepatitis B virus infection and immunosuppressive therapy in patients with inflammatory bowel disease.

R. Marmo, N. Caporaso, F. Morisco, 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Occult hepatitis B and infliximab-induced HBV reactivation.

M. Cottone, A. Orlando, F. Rossi, 2007, Inflammatory bowel diseases.

Incidence of Crohn’s disease and CARD15 mutation in a small township in Sicily

M. Cottone, W. Fries, A. Orlando, 2007, European Journal of Epidemiology.

Hospital incidence of Crohn's disease in the province of Palermo. A preliminary report.

M. Cottone, A. Orlando, L. Pagliaro, 1989, Scandinavian journal of gastroenterology. Supplement.

Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy.

A. Gasbarrini, V. Annese, L. Guidi, 2014, Journal of Crohn's & colitis.

Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis.

G. Pietrosi, A. Rizzo, G. Martorana, 2001 .

Adalimumab in steroid‐dependent Crohn's disease patients: Prognostic factors for clinical benefit

M. Cottone, A. Orlando, M. Cappello, 2012, Inflammatory bowel diseases.

Familial Occurrence of Inflammatory Bowel Disease in Celiac Disease

G. Martorana, E. Calabrese, M. Cottone, 2002, Inflammatory bowel diseases.

Letter: psoriasiform eruption during vedolizumab therapy

A. Orlando, S. Renna, M. R. Bongiorno, 2019, Alimentary pharmacology & therapeutics.

The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper.

I. Olivieri, G. Girolomoni, G. Fiorino, 2014, Autoimmunity reviews.

Inflammatory Bowel Disease Onset During Secukinumab Treatment: Real Concern or Just an Expression of Dysregulated Immune Response?

G. Trifirò, W. Fries, A. Orlando, 2019, Clinical Drug Investigation.

An update on medical management on Crohn’s disease

M. Cottone, A. Orlando, A. Affronti, 2015, Expert opinion on pharmacotherapy.

Clinical implications of mucosal healing in the management of patients with inflammatory bowel disease.

F. Guglielmi, M. Cottone, A. Orlando, 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study.

F. Rizzello, L. Biancone, F. Castiglione, 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Mesalazine for the treatment of inflammatory bowel disease

M. Cottone, A. Orlando, I. Modesto, 2013, Expert opinion on pharmacotherapy.

Combined treatment with adalimumab and surgery in a patient with steroid-dependent Crohn's disease complicated by perianal disease

G. Solina, M. Cottone, A. Orlando, 2010 .

Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy.

P. Gionchetti, F. Rizzello, M. Grova, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

SPOSAB ABP 501: A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501

A. Magnano, A. Busacca, F. Graziano, 2021, Journal of gastroenterology and hepatology.

Ustekinumab for treating ulcerative colitis: an expert opinion

P. Gionchetti, F. Rizzello, S. Danese, 2020, Expert opinion on biological therapy.

Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study.

A. Alibrandi, G. Fiorino, A. Armuzzi, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.

L. Guidi, A. Armuzzi, R. D'Incà, 2016, Journal of Crohn's & colitis.

Perianal Surgery in Crohn’s Disease

G. Solina, A. Orlando, S. Renna, 2016 .

A. Armuzzi, A. Orlando, F. Macaluso, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Relationship Between Site of Disease and Familial Occurrence in Crohn's Disease

M. Cottone, A. Orlando, C. Brignola, 2004, Digestive Diseases and Sciences.

P452 Increasing interobserver agreement on IBD endoscopic scoring systems: results from the IGIBDEndo educational program

F. Rizzello, A. Armuzzi, R. D'Incà, 2014 .

The Addition of an Immunosuppressant After Loss of Response to Anti-TNFα Monotherapy in Inflammatory Bowel Disease: A 2-Year Study.

M. Cottone, A. Orlando, S. Renna, 2018, Inflammatory bowel diseases.

Selective Use of Combination Therapy in Patients With Infliximab-resistant Inflammatory Bowel Disease: Data From a Tertiary Referral Center.

M. Cottone, A. Orlando, S. Renna, 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

The Selective Use of Combination Therapy in Patients with Inflammatory Bowel Disease Resistant to Anti-TNF: to Whom, How and How Long?

M. Cottone, A. Orlando, F. Macaluso, 2016, Journal of Crohn's & colitis.

Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis.

V. Giambra, G. Gasbarrini, D. Frezza, 2008, The Journal of investigative dermatology.

Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study.

V. Annese, P. Gionchetti, M. Campieri, 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

MESENCHIMAL STEM CELLS IN INFLAMMATORY BOWEL DISEASES: CLINICAL EVIDENCES AND POTENTIAL INSIGHTS FOR THE CLINICIANS

Criscuoli, G. Damiano, V. Palumbo, 2013 .

Effect of immunosuppressive therapy on patients with inflammatory bowel diseases and hepatitis B or C virus infection

R. Marmo, N. Caporaso, F. Morisco, 2013, Journal of viral hepatitis.

Physicians’ Knowledge and Application of Immunization Strategies in Patients with Inflammatory Bowel Disease: A Survey of the Italian Group for the Study of Inflammatory Bowel Disease

A. Armuzzi, S. Ardizzone, M. Cottone, 2019, Digestion.

Prevention of postsurgical relapse and recurrence in Crohn's disease

E. Calabrese, M. Cottone, A. Orlando, 2003 .

Barriers to anti‐TNFalpha prescription among Italian physicians managing inflammatory bowel disease

F. Rizzello, A. Armuzzi, G. Manes, 2019, GastroHep.

Sa1270 Early Post-Operative Endoscopic Recurrence in Crohn's Disease Patients: Data From a Large Prospective Italian Multicenter Cohort

V. Annese, P. Gionchetti, F. Rizzello, 2012 .

Can the serological status of “anti‐HBc alone” be considered a sentinel marker for detection of “occult” HBV infection?

V. Meli, A. Orlando, A. Tagger, 2008, Journal of medical virology.

Gastrointestinal lesions associated with spondyloarthropathies.

M. Cottone, A. Orlando, S. Renna, 2009, World journal of gastroenterology.

Pyoderma Gangrenosum in An Ulcerative Colitis Pediatric Patient During Vedolizumab Therapy Successfully Treated With Oral Cyclosporine.

F. Graziano, A. Orlando, F. Macaluso, 2021, Inflammatory bowel diseases.

Multifocal pyoderma gangrenosum resistant to infliximab in active ulcerative colitis: don't forget the role of cyclosporin.

M. Cottone, A. Orlando, E. Sinagra, 2012, Inflammatory bowel diseases.

A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis.

A. Magnano, F. Graziano, M. Cottone, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study.

M. Latteri, G. Cabibbo, A. Orlando, 2005, Journal of hepatology.

Anti-interleukin-12 and anti-interleukin-23 agents in Crohn’s disease

M. Cottone, A. Orlando, F. Macaluso, 2018, Expert opinion on biological therapy.

Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease.

I. Olivieri, P. Gionchetti, A. Armuzzi, 2014, Autoimmunity reviews.

Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease

I. Olivieri, A. Costanzo, P. Gionchetti, 2018, Advances in Therapy.

Biliary Sludge and Gallstones in Pregnancy: Incidence, Risk Factors, and Natural History

M. Raimondo, L. Barresi, A. Orlando, 1993, Annals of Internal Medicine.

AISF position paper on HCV in immunocompromised patients

R. Bruno, B. Daniele, P. Lampertico, 2019, Digestive and Liver Disease.

Medical Treatment of Perianal Crohn’s Disease

G. Solina, M. Cottone, A. Orlando, 2016 .

IL-23R determines susceptibility in Crohn's disease in a Mediterranean area.

M. Cottone, A. Orlando, A. Maggio, 2009, Inflammatory bowel diseases.

Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease.

Maria Fichera, Markus F Neurath, Vincenzo Savarino, 2015, The New England journal of medicine.

Effectiveness and safety of biologics in pediatric inflammatory boweldisease: Real-life data from the Sicilian Network.

M. Cottone, A. Orlando, S. Pellegrino, 2020, Clinics and research in hepatology and gastroenterology.

Infliximab in severe ulcerative colitis: short‐term results of different infusion regimens and long‐term follow‐up

A. Gasbarrini, V. Annese, A. Armuzzi, 2007, Alimentary pharmacology & therapeutics.

One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy

A. Alibrandi, F. Scaldaferri, A. Armuzzi, 2021, Expert opinion on biological therapy.

Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease.

A. Gasbarrini, E. Savarino, F. Scaldaferri, 2020, Journal of Crohn's & colitis.

Randomized controlled trials in perianal Crohn's disease.

M. Cottone, A. Orlando, S. Renna, 2012, Reviews on recent clinical trials.

Leukocytapheresis in patients with moderate-severe steroid-dependant ulcerative colitis: clinical response without endoscopic response.

M. Cottone, A. Orlando, I. Modesto, 2006, Inflammatory bowel diseases.

Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts.

I. Olivieri, P. Gionchetti, A. Armuzzi, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Blood-based prognostic biomarkers in Crohn’s Disease patients on biologics: a promising tool to predict endoscopic outcomes

M. Grova, A. Orlando, R. Di Mitri, 2021, Expert opinion on biological therapy.

Female reproductive health and inflammatory bowel disease: A practice-based review.

F. Rizzello, A. Armuzzi, S. Mazzuoli, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel disease.

A. Orlando, A. Cascio, S. Renna, 2017, The Journal of infection.

The Role of Portal Vein Thrombosis in the Clinical Course of Inflammatory Bowel Diseases: Report on Three Cases and Review of the Literature

M. Cottone, A. Orlando, I. Modesto, 2012, Gastroenterology research and practice.

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

Pietro Andreone, Franco Trevisani, F. Trevisani, 2002, Radiology.

Efficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn's disease strictures.

G. D’Amico, M. Cottone, A. Orlando, 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort.

V. Annese, P. Gionchetti, F. Rizzello, 2014, Journal of Crohn's & colitis.

Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD).

F. Rizzello, R. D'Incà, G. Lombardi, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn's disease: a comparison with ultrasound.

F. Castiglione, M. Cottone, A. Orlando, 2006, European review for medical and pharmacological sciences.

Postoperative maintenance therapy for inflammatory bowel disease

M. Cottone, A. Orlando, I. Modesto, 2006, Current opinion in gastroenterology.

Unusual perforation after balloon dilation in a Crohn's disease patient: report of a case.

G. Solina, M. Cottone, A. Orlando, 2011, Journal of Crohn's & Colitis.

Infliximab prevents Crohn’s disease recurrence after ileal resection

M. Cottone, A. Orlando, F. Mocciaro, 2009, Expert Review of Gastroenterology & Hepatology.

Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS‐CoV‐2 infection: an IG‐IBD study

P. Balestrieri, G. Fiorino, A. Armuzzi, 2021, Alimentary pharmacology & therapeutics.

HLA antigens in ulcerative colitis: a study in the Sicilian population.

C. Caruso, M. Cottone, A. Orlando, 2008, Tissue antigens.

Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19

A. Magnano, W. Fries, A. Orlando, 2022, Inflammatory bowel diseases.

Could Patients With Inflammatory Bowel Disease Treated With Immunomodulators or Biologics Be at Lower Risk for Severe Forms of COVID-19?

A. Orlando, F. Macaluso, 2020, Gastroenterology.

Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease

A. Magnano, M. Grova, W. Fries, 2021, Digestive and Liver Disease.

The key role of colonoscopy at 6 months from ileocolonic resection in Crohn's disease patients.

A. Orlando, F. Mocciaro, S. Renna, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational study.

M. Cottone, A. Orlando, E. Sinagra, 2012, Journal of Crohn's & colitis.

Review article: prevention of postsurgical relapse and recurrence in Crohn's disease.

E. Calabrese, M. Cottone, A. Orlando, 2003, Alimentary pharmacology & therapeutics.

W1113 Efficacy and Safety of Endoscopic Balloon Dilation of Symptomatic Intestinal Crohn's Disease Strictures

G. D’Amico, M. Cottone, A. Orlando, 2009 .

The involvement of IgH enhancer HS1.2 in the pathogenesis of Crohn's disease: how the immune system can influence a multifactorial disease.

R. Marmo, D. Pagliari, D. Frezza, 2016, European review for medical and pharmacological sciences.

Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study

W. Fries, A. Orlando, M. Cappello, 2020, United European gastroenterology journal.

P387 The addition of an immunosuppressant is an effective optimization strategy after loss of response to anti-TNF-alpha monotherapy in patients with inflammatory bowel disease: a two-year experience.

M. Cottone, A. Orlando, S. Renna, 2017, Journal of Crohn's & colitis.

798 – Efficacy and Safety of Open-Label Treatment with Tofacitinib 10 Mg Twice Daily in Patients with Ulcerativ Ecolitis with Clinical Response, But Not Remission, After 52 Weeks of Maintenance Therapy: Data from the Octave Studies

A. Thorpe, C. Nduaka, G. Friedman, 2019, Gastroenterology.

DOP41 Efficacy and safety of open-label treatment with tofacitinib 10 mg twice daily in patients with ulcerative colitis with clinical response, but not remission, after 52 weeks of maintenance therapy: data from the OCTAVE studies

A. Thorpe, C. Nduaka, G. Friedman, 2019, Journal of Crohn's and Colitis.

Corrigendum to "Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease" [Dig. Liver Dis. 48 (2016) 360-370].

P. Gionchetti, F. Rizzello, S. Danese, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Lupus-like reactions in patients with inflammatory bowel disease treated with anti-TNFs are insidious adverse events: data from a large single-center cohort

M. Cottone, A. Orlando, S. Renna, 2019, Scandinavian journal of gastroenterology.

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.

Teck Kiang Tan, J. Mansfield, Fraser Cummings, 2021, The lancet. Gastroenterology & hepatology.

Could JC virus provoke metastasis in colon cancer?

A. Rizzo, G. Tomasello, A. L. Lo Monte, 2014, World journal of gastroenterology.

A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease

A. Busacca, M. Cottone, W. Fries, 2020, Journal of gastroenterology and hepatology.

LOW-GRADE CHRONIC INFLAMMATION MEDIATED BY MAST CELLS IN FIBROMYALGIA : ROLE OF IL-37

G. Solina, A. Rizzo, G. Tomasello, 2018 .

Ustekinumab in the management of Crohn's disease: Expert opinion.

P. Gionchetti, F. Rizzello, S. Danese, 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease

A. Rizzo, F. Ciccia, M. Cottone, 2017, Annals of the rheumatic diseases.

Oral lichen planus after certolizumab pegol treatment in a patient with Crohn's disease.

M. Cottone, A. Orlando, F. Mocciaro, 2011, Journal of Crohn's & colitis.

Radiofrequency Thermal Ablation vs. Percutaneous Ethanol Injection for Small Hepatocellular Carcinoma in Cirrhosis: Meta-Analysis of Randomized Controlled Trials

Angelo Andriulli, Gioacchino Leandro, A. Andriulli, 2009, The American Journal of Gastroenterology.

Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: a validated prognostic model

T. Livraghi, M. Cottone, A. Orlando, 2000, American Journal of Gastroenterology.

Sarcopenia is a negative predictive factor for endoscopic remission in patients with Crohn's disease treated with biologics

M. Grova, A. Orlando, M. Maida, 2023, Digestive and Liver Disease.

Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)

A. Alibrandi, A. Magnano, M. Cottone, 2020, Drugs & Aging.

Rescue Therapy with Intensive Vedolizumab Optimization in a Seventeen-Year-Old Girl with Acute Severe Ulcerative Colitis

F. Graziano, A. Orlando, F. Macaluso, 2021, Digestive Diseases and Sciences.

Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresis.

M. Cottone, A. Orlando, V. Criscuoli, 2009, Inflammatory bowel diseases.

Clinical course of severe colitis: a comparison between Crohns Disease and ulcerative colitis.

G. Solina, F. Cappello, A. Rizzo, 2018, Journal of Biological Regulators and Homeostatic Agents.

Head-to-head comparison of biological drugs for inflammatory bowel disease: from randomized controlled trials to real-world experience

M. Grova, A. Orlando, M. Maida, 2021, Therapeutic advances in gastroenterology.

Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab

M. Cottone, A. Orlando, S. Renna, 2018, Alimentary pharmacology & therapeutics.

Prurigo nodularis of Hyde treated with low-dose thalidomide.

M. Cottone, A. Orlando, S. Renna, 2009, European review for medical and pharmacological sciences.

A. Gasbarrini, E. Savarino, F. Manguso, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Letter: SPOSIB SB2—a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2

A. Magnano, M. Cottone, W. Fries, 2019, Alimentary pharmacology & therapeutics.

Use of biologics for the management of Crohn's disease: IG-IBD technical review based on the GRADE methodology.

S. Bonovas, Claudia Pansieri, A. Armuzzi, 2023, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Anti-TNF Combination Therapy in Inflammatory Bowel Disease: de novo or selective?

A. Orlando, F. Macaluso, 2019, Minerva gastroenterologica e dietologica.

An unusual presentation of T-lymphoma in a Crohn's disease patient treated with combo therapy: we are willing to take a risk of serious adverse events for a doubtful benefit?

M. Cottone, A. Orlando, E. Sinagra, 2012, Journal of Crohn's & Colitis.

Infliximab, azathioprine or combination therapy in the treatment of active Crohn’s disease

M. Cottone, A. Orlando, C. Papi, 2010, Expert review of gastroenterology & hepatology.

A Systematic Review on Infliximab Biosimilar SB2: From Pre-Clinical Data to Real-World Evidence

R. Atreya, A. Orlando, F. Macaluso, 2021, Expert opinion on biological therapy.

OC.12.1 INTEROBSERVER AGREEMENT IN IBD SCORES REQUIRES EXPERTISE AND EDUCATION: PRELIMINARY RESULTS FROM AN ONGOING IG-IBD STUDY

F. Rizzello, R. D'Incà, L. Biancone, 2012 .

Increased risk of pneumonia among patients with inflammatory bowel disease: a comparison between patients treated with biologic therapies and with conventional drugs.

M. Cottone, A. Orlando, V. Criscuoli, 2013, Journal of Crohn's & Colitis.

Placebo therapy in Crohn's disease.

M. Cottone, A. Orlando, F. Mocciaro, 2009, European journal of internal medicine.

Ustekinumab in Crohn's disease: Real‐world outcomes from the Sicilian network for inflammatory bowel diseases

A. Alibrandi, A. Magnano, M. Grova, 2021, JGH open : an open access journal of gastroenterology and hepatology.

Improving patients' QoL: how the success of treatment can improve workability

M. Cottone, A. Orlando, F. Mocciaro, 2008 .

Translation and initial validation of the Medication Adherence Report Scale (MARS) in Italian patients with Crohn's Disease.

R. Horne, P. Usai, G. delle Fave, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Risk of Pneumonia Caused by Pneumocystis jiroveci in Inflammatory Bowel Disease: The Role of Concomitant Pulmonary Comorbidities.

M. Cottone, A. Orlando, F. Macaluso, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

OP005 The PROSIT cohort of infliximab biosimilar in IBD: a prolonged follow-up on the efficacy and safety across Italy.

A. Andriulli, V. Annese, A. Amato, 2017, Journal of Crohn's & colitis.

Letter: golimumab efficacy in patients with Crohn's disease and concomitant severe arthritis

A. Orlando, S. Renna, G. Provenzano, 2020, Alimentary pharmacology & therapeutics.

Switching from SB2 to PF-06438179/GP1111 and back in inflammatory bowel disease: "The Superswitchers".

M. Grova, A. Orlando, S. Renna, 2023, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD technical review based on the GRADE methodology.

S. Bonovas, Claudia Pansieri, A. Armuzzi, 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Factors Affecting Clinical and Endoscopic Outcomes of Placebo Arm in Trials of Biologics and Small Molecule Drugs in Ulcerative Colitis: A Meta-Analysis.

M. Cottone, A. Orlando, M. Maida, 2019, Inflammatory bowel diseases.

P452 Increasing interobserver agreement on IBD endoscopic scoring systems: results from the IGIBDEndo educational program

F. Rizzello, A. Armuzzi, R. D'Incà, 2014 .

P289 Concordance in IBD endoscopic scoring requires expertise and training: Preliminary results of an ongoing IG-IBD study

F. Rizzello, R. D'Incà, L. Biancone, 2012 .

Is 5-ASA still the treatment of choice for ulcerative colitis?

M. Cottone, A. Orlando, I. Modesto, 2011, Current drug targets.

Effectiveness and safety of an on-demand ferric carboxymaltose infusion strategy in patients with inflammatory bowel disease: a real world experience

M. Grova, A. Orlando, M. Maida, 2022, European journal of gastroenterology & hepatology.

Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease

G. Corazza, E. Savarino, G. Fiorino, 2023, Frontiers in Medicine.

Treatment of small hepatocellular carcinoma associated with cirrhosis by percutaneous ethanol injection. A trial with a comparison group.

M. Cottone, A. Orlando, M. Caltagirone, 1997, Scandinavian journal of gastroenterology.

Is splenectomy a treatment option for aseptic abscesses in patients with Crohn's disease?

M. Cottone, A. Orlando, F. Mocciaro, 2009, European Journal of Gastroenterology and Hepathology.

Is Epstein-Barr virus infection associated with the pathogenesis of microscopic colitis?

A. Rizzo, S. Sferrazza, M. Cottone, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology.

S. Bonovas, E. Savarino, F. Manguso, 2023, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-&agr; Inhibitor-naïve and Non-naïve Patients With Crohn’s Disease: Real-Life Data From the Sicilian Network for Inflammatory Bowel Disease

A. Magnano, M. Cottone, W. Fries, 2018, Journal of Crohn's & colitis.

Internet use among inflammatory bowel disease patients: an Italian multicenter survey

L. Guidi, S. Danese, S. Ardizzone, 2009, European journal of gastroenterology & hepatology.

Ultrasound in Crohn's disease--a comparison with small bowel enema.

M. Cottone, A. Orlando, A. Maringhini, 1986, Rays.

The effectiveness of ustekinumab and vedolizumab as third-line biologic therapy in patients with Crohn's disease.

M. Grova, W. Fries, A. Orlando, 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

OC.02.3 A PROPENSITY SCORE WEIGHTED COMPARISON OF VEDOLIZUMAB, ADALIMUMAB, AND GOLIMUMAB IN PATIENTS WITH ULCERATIVE COLITIS: REAL-LIFE DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)

A. Magnano, F. Graziano, M. Cottone, 2020 .

Early postoperative recurrence of severe Crohn's disease, with colonic involvement and associated human cytomegalovirus infection, treated with oral valganciclovir and adalimumab.

M. Cottone, A. Orlando, E. Sinagra, 2011, Inflammatory bowel diseases.

Effectiveness and safety of Ustekinumab for the treatment of Crohn’s disease in real-life experiences: a meta-analysis of observational studies

M. Cottone, A. Orlando, M. Maida, 2019, Expert opinion on biological therapy.

Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD)

G. Fiorino, F. Caprioli, F. Castiglione, 2023, European journal of gastroenterology & hepatology.

Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study

A. Amato, G. Fiorino, F. Caprioli, 2022, Digestive and Liver Disease.

Reply to Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease”

A. Orlando, F. Macaluso, 2022, Digestive and Liver Disease.

An Unusual Presentation of Zollinger-Ellison Syndrome

A. Rizzo, M. Cottone, A. Orlando, 2013, Case Reports in Gastroenterology.

439 The PROSIT-BIO Cohort of the IG-IBD: A Prospective Observational Study of Patients With Inflammatory Bowel Disease Treated With Infliximab BioSimilars

V. Annese, A. Amato, G. Fiorino, 2016 .

[Evolution of the echographic picture in primary liver tumor associated with cirrhosis].

M. Cottone, A. Orlando, M. Caltagirone, 1989, La Radiologia medica.

Acute-severe fatigue after anti-TNFα treatment: an early insidious side effect.

A. Orlando, R. Di Mitri, F. Mocciaro, 2013, Journal of Crohn's & colitis.

Is really megacolon a contraindication to infliximab in Crohn's disease?

M. Cottone, A. Orlando, V. Criscuoli, 2013, Acta gastro-enterologica Belgica.

Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab.

P. Usai, A. Armuzzi, L. Biancone, 2019, Inflammatory bowel diseases.

JC Virus, Helicobacter pylori, and Oesophageal Achalasia: Preliminary Results from a Retrospective Case–Control Study

G. D’Amico, A. Rizzo, M. Cottone, 2013, Digestive Diseases and Sciences.

Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus

G. Liguori, P. Gionchetti, F. Rizzello, 2019, Gastroenterology research and practice.

Asymptomatic hepatocellular carcinoma in Child's A cirrhosis. A comparison of natural history and surgical treatment.

M. Cottone, A. Orlando, F. Tiné, 1989, Gastroenterology.

SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves

A. Amato, V. Gerardi, F. Scaldaferri, 2023, BMC Gastroenterology.

Ustekinumab is a promising option for the treatment of postoperative recurrence of Crohn's disease.

M. Grova, W. Fries, A. Orlando, 2023, Journal of gastroenterology and hepatology.

Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants.

M. Cottone, A. Orlando, M. Maida, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis.

A. Magnano, M. Cottone, W. Fries, 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Delayed-Onset Superior Mesenteric Artery Syndrome Presenting as Oesophageal Peptic Stricture

G. D’Amico, A. Orlando, E. Sinagra, 2012, Case Reports in Gastroenterology.

Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis.

G. Pietrosi, A. Rizzo, G. Martorana, 2001 .

An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors

F. Manguso, G. Fiorino, M. Grova, 2022 .

P.07.2 OUTCOME IN ULCERATIVE COLITIS AFTER SWITCH FROM SUBCUTANEOUS ANTI-TNF TO INTRAVENOUS ANTI-TNF: A MULTICENTRE STUDY

G. Fiorino, A. Armuzzi, R. D'Incà, 2018 .

P412 The Sicilian network of biological therapy in inflammatory bowel disease: preliminary data on efficacy.

A. Magnano, M. Cottone, W. Fries, 2017, Journal of Crohn's & Colitis.

W1257 Infliximab for Severe Ulcerative Colitis: Short-Term and One Year Outcome of Three Dose Regimen. An Italian Multicentre Open-Label Study

V. Annese, L. Guidi, A. Armuzzi, 2010 .

Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study.

G. Fiorino, F. Caprioli, F. Castiglione, 2023, Inflammatory bowel diseases.

Safety and effectiveness of tofacitinib in ulcerative colitis: Data from TOFA-UC, a SN-IBD study.

M. Grova, A. Orlando, M. Cappello, 2023, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Incident Colorectal Cancer in Inflammatory Bowel Disease

L. Guidi, A. Armuzzi, R. D'Incà, 2022, Cancers.

Effectiveness and safety of tofacitinib for the treatment of ulcerative colitis: A single-arm meta-analysis of observational studies.

A. Orlando, M. Maida, F. Macaluso, 2021, Digestive and Liver Disease.

Transcatheter arterial chemoembolisation for hepatocellular carcinoma in cirrhosis: survival rate and prognostic factors.

F. Valenza, M. Cottone, A. Orlando, 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Clinical course of ulcerative colitis.

A. Orlando, F. Mocciaro, D. Scimeca, 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

TOPIC HIGHLIGHT

M. Cottone, A. Orlando, I. Modesto, 2012 .

Toxic megacolon and human Cytomegalovirus in a series of severe ulcerative colitis patients.

M. Cottone, A. Orlando, V. Criscuoli, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

The biologics of ulcerative colitis

M. Cottone, A. Orlando, S. Renna, 2017, Expert opinion on biological therapy.

Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease.

V. Annese, P. Gionchetti, F. Rizzello, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy.

V. Annese, A. Amato, F. Perri, 2018, Inflammatory bowel diseases.

AISF position paper on HCV in immunocompromised patients.

R. Bruno, B. Daniele, P. Lampertico, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies.

A. Orlando, F. Macaluso, M. Ventimiglia, 2023, Journal of Crohn's & colitis.